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Connective tissue manipulation or connective tissue massage 
(bindegewebsmassage) is a manual reflex therapy in that it is applied with the 
therapist’s hands which are in contact with the patient’s skin. The assessment of the 
patient and the clinical decision-making that directs treatment is based on a 
theoretical model that assumes a reflex effect on the autonomic nervous system 
which is induced by manipulating the fascial layers within and beneath the skin to 
stimulate cutaneo-visceral reflexes. This paper reviews the literature and current 
research findings to establish the theoretical framework for CTM and the evidence 
for its clinical effects. The rationale for the principles of treatment will be discussed, 
and the evidence for the clinical effectiveness assessed through an analytical review 






















Connective Tissue Manipulation (CTM) is a manual reflex therapy which was 
originally known as Bindegewebsmassage. It was developed in Germany from the 
1930s onwards, spread throughout Europe and was introduced to the UK in the 
1950s as Connective Tissue Massage (Holey, 1995a; Holey, 2000). It was 
subsequently, from the 1980s, referred to as Connective Tissue Manipulation 
(Ebner, 1980), as the term massage was thought to be misleading in this context. 
The terms are used synonymously in the literature and in this review. 
 
CTM is a manual reflex therapy in that it is applied with the therapist’s hands which 
are in contact with the patient’s skin. The assessment of the patient and the clinical 
decision-making that directs treatment is based on a theoretical model that assumes 
a reflex effect on the autonomic nervous system which is induced by manipulating 
the fascial layers within and beneath the skin.  
 
This paper reviews the literature and current research findings to establish the 
theoretical framework for CTM and the evidence for its clinical effects. The specificity 
of CTM as a treatment approach warrants some explanation, so for this purpose, 
reference to textbook literature has been included. The rationale for the principles of 
treatment will be discussed and the evidence for its clinical effectiveness will be 









CTM is used within the bodyworker’s scope of practice, and, based on clinical 
experience, can be effective in treating four types of clinical problem. These are 
either zonal, where the autonomically-induced changes in the tissues of the reflex 
zone themselves are thought to be producing symptoms; hormonal/endocrine (such 
as menopausal or menstrual problems, diabetes if within the therapist’s scope of 
practice); local mechanical/musculoskeletal (chronic nerve root pain, for example); or 
other symptoms, not fitting into these categories, resulting from a general autonomic 
imbalance (such as sleeplessness, restlessness and anxiety after screening for 
mental health problems). Several of these categories often co-exist and the problem 
often presents as a painful condition.  Where pain is understood to have an 
autonomic component, this indicates the patient’s suitability for CTM as an 
intervention. At the initial assessment, the signs and symptoms build into a picture of 
skin and fascial changes with diverse but autonomically linked symptoms.  The 
connective tissue changes may appear in a region some distance away from the 
symptoms, in reflex zones which can be seen and palpated and also anatomically 
explained.  CTM is therefore distinguished from other therapeutic approaches which 
involve manipulation of connective tissue, by being based on the reflex zones of 
Head (Ebner, 1980). It is also characterised by the specific principles which are 
followed by the practitioner and the type of manual stroke used. 
 
Head’s Connective Tissue Zones are areas of the skin and superficial connective 
tissue which appear to be indrawn and feel tight or adherent in chronic situations or 
‘puffy’ and swollen in acute conditions. They share the same spinal segment as their 
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related organ or physiological function although the downwards pull of gravity on skin 
makes them appear a little lower (Holey, 1995b). The heart zone covers the posterior 
skin area over the left side of the thorax, levels T1-5 and corresponds with the 
sympathetic innervation of the heart. (Holey 1995a). Head identified these by linking 
the tissue changes to symptoms, and Tierich-Leube, in particular, added further 
clarification based on her experience of observing therapeutic effects of their 
manipulation. It has been postulated that a specific effect can be obtained on a 
structure by targeting treatment within the relevant zone via the cutaneo-visceral 
reflex, but also that a positive effect is obtained through stimulation of the 
suprasegmental cutaneo-visceral reflex. This could explain why patients often 
improve considerably by treatment of the ‘Basic section’ wherever the problem lies. 
 
The stroke is highly specific in two ways. Firstly, the hand positions are important to 
ensure that sufficient and appropriately-directed traction is exerted at the tissue 
interfaces. The most effective ways are through the pad of the longest (usually 
middle) finger or the ends of the thumbs. 
 
Secondly, as the aim is to reach the fascial interface, patterns of strokes are used to 
enable access to the deep fascia where it lies directly under the skin (Figure 1). This 
avoids uncomfortable side effects of treatment. Once the active (visible, palpable 
and symptomatic) or silent (visible, palpable but asymptomatic) Head’s zones are 
identified, they are linked to the symptoms to build a hypothesis of causation. A 
treatment plan is developed and the contraindications of acute inflammation, active 
infection, malignancy, unstable blood pressure/heart conditions, haemorrhage, early 




 The principles of treatment are: 
 
1. The skin must be displaced in relation to the underlying layer. This 
creates a shear force at the tissue interface. This mechanical deformation 
stimulates mechanoreceptors. It also activates mast cell secretion, potentially 
of histamine, nitric oxide, vasoactive intestinal polypeptide (a vasodilator) and 
heparin. These cells are present in large numbers around blood vessels 
(Theoharides et al., 2010). An accurate, skilled, CTM fascial stroke will often 
produce a triple response reaction of reddening and swelling in a line (wheal) 
but excessive or inaccurate strokes may produce skin irritation and 
discomfort. 
 
2. Work caudad to cephalad –treatment should start at the apex of the sacrum 
to desensitise the skin area which is reflexively linked to the parasympathetic 
nervous system (the “Bladder zone”, as the bladder has a parasympathetic 
nerve supply). This reduces sympathetic activity and starts to rebalance the 
autonomic nervous system in the desired direction. It also reduces potential 
unwanted reactions, which, if the principles are not followed, can include 
dizziness and sweating, fainting, extreme tiredness or irritability and 
restlessness. These effects are often delayed and may occur when the 
therapist is out of access, so must be avoided. They are most likely to happen 
if the skin over dense sympathetically-supplied areas (such as between the 





3. Work superficial to deep. It is the shear force applied to deep fascia of the 
fascial stroke which has the potent autonomic effect and this is the target 
tissue. However, most patients will have some oedema in the superficial 
fascia and skin, or some excess skin tension. If this is not dealt with first, the 
treatment will be painful as this type of skin is often tender to touch. The skin 
technique can reduce hypersensitivity. Pain increases sympathetic activity so 
will undermine achievement of the intended outcomes. Uncomfortable 
sensations may also occur such as itching, dull pressure or a prolonged 
sensation of the treatment strokes for several hours post-treatment. These 
can be avoided by clearing the skin of excess fluid and tension before moving 
to deeper layers. The subcutaneous and flashige strokes are used for this 
purpose. 
 
4. Target appropriate tissue interfaces to stimulate the fascia. The strokes 
are undertaken in specific patterns. These patterns correlate to places where 
the deep fascia lies under the skin, rather than under muscle. This enables 
the fascia to be targeted at the correct tissue interface, so reducing unwanted 
reactions and also ensuring that the clinical effects can be produced in as few 
treatment sessions as possible, as this is beneficial to the patient. Where the 
deep fascia is stimulated, a non-painful sharp or ‘cutting’ sensation is felt by 
the patient. Where CTM is applied this precisely, few stroke repetitions are 







The technique aims to stimulate the autonomic nervous system to re-balance the 
parasympathetic and sympathetic systems, usually moving in a parasympathetic 
direction. It recognises changes in Head’s zones to objectively establish causative 
factors and severity of autonomic imbalance, linking these with subjective symptoms. 
These zonal areas are then used as treatment points. They are most easily detected 
on the back (see Figure 2), as this is where the gravitational pull on the skin in 
relation to its fascial underlayer is most apparent and practitioners have been found 
to be able to detect the zones with some reliability (Holey &  Watson, 1995). 
 
When the skin is moved on its fascial underlayer in a specific direction, a shear force 
is produced at the tissue interfaces. These are occupied by horizontal plexi of blood 
vessels and these blood vessels innervated by autonomic nerve endings. It is 
thought that this is how CTM produces its powerful autonomic stimulus (see Figure 
3). 
 
The symptoms affected are both segmental and suprasegmental. This means that a 
generalised autonomic effect will occur and a more evenly balanced autonomic 
system will be shown by an improved sleep pattern, release of endorphins (Kaada &  
Torsteinbo, 1989) giving a raise of mood, feeling of relaxation and normalised energy 
levels. A segmental effect is seen in an improved functioning of the tissues supplied 
by the same spinal segment of the reflex zone under treatment. This may be 
improved hydration and texture of the skin, increased circulation to all the structures, 
improved muscle tone and enhanced visceral function. With these improvements, 
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there is a reduction in pain and stiffness of tissue. This can be significant in 
conditions where there is intractable nerve root pain, stiff joints, chronic post-
operative pain and vaginal atrophy, among others. Whilst similar claims may be 
made for other forms of soft tissue therapies, the accompanying autonomic effects of 
CTM can be powerful and overdosing must be avoided. The effects are often 
achieved at some distance from where the therapy is applied and can be predicted 
through an understanding of the reflex mechanisms and controlled by application of 
sound clinical decision-making. 
 
Evidence for a physiological response  
There is some experimental evidence that CTM produces a measurable 
physiological response.  CTM has been shown to affect peripheral blood flow in a 
study of 18 men (Horstkotte et al., 1967), producing an immediate reduction in blood 
flow, followed by an increase after two weeks. Another study has shown that CTM 
produced an increased level of plasma beta-endorphins in 12 people with pain of 
various types (Kaada &  Torsteinbo, 1989).  
 
Holey et al (2011) reported evidence of CTM producing an immediate moderate 
increase in diastolic blood pressure (BP), but not in systolic BP, heart rate or foot 
temperature. Kisner & Taslitz (1968) also provided evidence that CTM produces 
increased sympathetic activity, and their data also suggest that the main effect was 
on diastolic BP rather than systolic. Reed and Held (1988) reported no CTM effect 
on mean arterial BP, however they did not report any actual data, and they did not 
differentiate between diastolic and systolic BP. Clinicians often subjectively observe 




Holey et al (2011) reported that the area in which a fascial technique was applied 
demonstrated an observable reddening of the skin and a significant increase in skin 
temperature (measured by thermography), at 15 minutes after treatment, which was 
maintained for at least an hour (the end of data collection). This was not observed 
where the flashige technique was applied. This evidence of a physiological 
difference in the effects of the two stokes confirms the assumptions which inform 
CTM.  
  
Overall, there is evidence that CTM produces effects on the autonomic nervous 
system, exhibited by various changes in physiological variables. Clearly, more 
physiological research is needed to fully understand the detailed mechanisms 
occurring during CTM, enhance the effectiveness of treatment, and reduce potential 





The aim of this section is to determine the clinical effectiveness of CTM by reviewing 
the evidence for the effect of CTM in clinical populations. In order to do this, a 
literature search was conducted in the electronic databases AMED, CINAHL, 
MEDLINE, from inception to Feb 2013, using the terms connective tissue 
manipulation, and connective tissue massage. In addition, hand searches were 
undertaken using references taken from articles. In the search process for this 
section, studies were included if they were: full length peer-reviewed articles written 
in English; trials applying CTM in adult clinical populations. Single case reports were 
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excluded. A total of 133 titles were retrieved in the search (AMED 27, CINAHL 37, 
MEDLINE 69), the number reducing to 114 when exact duplicates were removed by 
the EBSCO search system. Papers relevant to this area were reviewed to synthesise 
an evaluation of current knowledge regarding CTM and the clinical relevance of this 
treatment.  
 
Studies of the effect of CTM (only) with a controlled comparison group: 
Castro-Sanchez et al (2011) carried out a trial in which 98 people with type 2 
diabetes and stage I or II Peripheral Arterial Disease (58F, mean [SD] age 53.6 
[11.7] years) were randomised to a CTM treatment group and a control group (each 
n= 49). CTM was given (2 x1 hour session per week) for a duration of 15 weeks. The 
CTM consisted of initial lumbo-sacral and pelvic strokes, a standardised series of 
strokes to the spinal axis, then a series of strokes to the lower limbs. A placebo 
control of sham magnetotherapy to the lower back and popliteal region was used. In 
post-intervention comparisons, the CTM group displayed significant improvements in 
numerous variables such as differential segmental BP, improved blood flow, foot 
temperature and oxygen saturation, and walking distance scores. The between-
group comparisons also showed significant differences and these improvements did 
not occur in the placebo control group. The improvements in most measures 
remained statistically significant at 6 months and 1 year time-points. 
 
Ülger et al (2002) carried out a trial in which 34 lower limb amputees (mean age 55 
years, gender not stated) with thromboangiitis obliterans (Buerger’s disease) were 
randomised to 3 groups: CTM; interferential therapy; or control. CTM was applied to 
all three groups who received the control treatment of standard exercises and 
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prosthetic training. The CTM and interferential therapy group received 20 sessions of 
daily treatment, 10 minutes per session. CTM was applied to the lumbo-sacral area 
for the first 2-3 sessions and then also to the lower extremities (no detail is given). 
No between-group statistical comparisons were carried out. The reduction in pain 
(VAS) was statistically significant in all three groups after treatment. The mean (SD) 
VAS pain values (pre & post) were: CTM 7.5 (1.9), 1.4 (0.9); interferential therapy 
8.2 (1.0), 0.8 (0.8); control 7.8 (1.1), 2.5 (1.0), and provide tentative evidence that the 
addition of CTM to the exercise treatment was beneficial. However, as a potential 
confounding variable, it should also be noted that the while the latter 2 groups had 
an equal balance of trans-tibial and trans-femoral amputees (50%), the CTM group 
were 2/3 trans-tibial amputees (8 of 12).  
 
Brattberg (1999) evaluated the effect of 10 weeks of CTM (15 treatments) in a trial of 
48 people with fibromalgia (mean [SD] age 40.9 [7.7] years, headache duration 14.2 
[5.5] years). Participants were randomised to a CTM treatment group (n= 23) and a 
“reference” group (n=25). This study is difficult to evaluate because it states it had 
two stages, and the reference group appear to have received CTM in the second 
stage. The author reports that immediately after the 10 week intervention, current 
pain was significantly better in the CTM group, but average pain did not differ 
between groups. Quality of life as measured by the Fibrositis Impact Questionnaire 
was significantly better in the CTM group. Scores on the Hospital Anxiety and 
Depression Scale showed a trend for a difference between the groups. The author 
noted that the CTM treatment effect did fade: after 6 months, pain had returned to 
90% of baseline values. These results show positive CTM effects, but it is not clear 




For these three studies, we used the PEDro scale (http://www.pedro.org.au/) to 
evaluate the quality (internal validity) of the studies. A PEDro score was already 
available at the PEDro website for Brattberg (1999), and was checked by the 
authors. The score was calculated by the authors for Ülger et al (2002) and Castro-
Sanchez et al (2011). The scores were: Castro-Sanchez et al (2011) 6/10; Brattberg 
(1999) 5/10; Ülger et al (2002) 4/10. All had random allocation, low levels of drop-
out, but a lack of blinding which can be common in rehabilitation research. 
 
Combination studies, or studies without a control group: 
In the context of the aim of determining the clinical effect of CTM, unfortunately most 
of the studies retrieved in the search show particular limitations, specifically having 
either no control group, or having CTM applied as an experimental treatment in 
combination with another treatment (i.e. the experimental intervention was not only 
CTM). The former is problematic because a control group is a vital part of any trial, 
either using usual care or no treatment (Altman, 1991; Domholt, 1993; Pocock, 
1983), with both and new treatments being compared concurrently (Bland, 2000). 
The latter type of design (CTM plus another treatment) means that inferences can 
only be made about that joint treatment, not about CTM alone: it cannot isolate the 
treatment effect of CTM (Domholt, 1993). The following studies fit into these 
categories. They are discussed briefly as, although the true effect of CTM cannot be 
inferred from these studies, they nevertheless provide some information on CTM as 




Citak-Karakaya et al (2006) reported improvement in the symptoms of 20 women 
with fibromyalgia following CTM in combination with ultrasound therapy (ultrasound 
and high-voltage pulsed galvanic stimulation). The study incorporated no control 
group, and additionally because the CTM was applied in combination with other 
treatments, the true effect of the actual CTM is difficult to ascertain. The authors 
point out how ultrasound and galvanic stimulation may both have positive effects, 
and do state that it is difficult to determine which treatment produced the 
improvements. Furthermore, they do make clear that placebo effects or natural 
history may be confounding variables in their findings. 
 
Akbayrak et al (2001) investigated the effect of CTM in conjunction with classical 
massage and hot pack application on women with migraine. They found improved 
VAS pain scores. However as this study has no control group, and also a mixed 
treatment, it is difficult to be certain of the actual CTM effect in the study. Akbayrak et 
al (2002) found four weeks (20 treatments) of CTM produced improvements in pain 
intensity, duration and frequency at 6 month follow-up in 20 people with tension type 
headache. However, the lack of a control group means that isolating the CTM effect 
from other effects such as placebo is difficult.  
 
Maddali Bongi et al (2009) investigated the effect of a combination of CTM and 
McMennell joint manipulation. They randomised 40 people with systemic sclerosis to 
receive this combination treatment and home exercise, or a home exercise control 
treatment, for 9 weeks. There were statistically significant improvements in various 
outcome measures such as SF-36 and Health Assessment Questionnaire in the 
intervention group, but not in the control group. Hand opening improved in both 
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groups. In similarly designed study by Maddali Bongi et al (2011), 40 people with 
systemic sclerosis were randomised to receive a combination of CTM, Kabat’s 
technique, kinesitherapy (facial exercises), and home exercises, or to receive home 
exercises alone. The intervention treatment was significantly better than the control 
home exercises for face and mouth-related symptoms, but neither group showed 
improvements in quality of life (SF36) or disability (Health Assessment 
Questionnaire). However in both of these studies, the combination of various 
treatments means that any CTM effect cannot be determined. 
 
Five other studies have investigated CTM without any control group in the study 
design. Demirturk et al (2002) carried out a randomised trial in which 35 patients with 
chronic tension-type headache were randomised to receive either CTM or Cyriax 
vertebral mobilisation for 20 sessions over 4 weeks. The study reported post-
treatment improvements for both groups in headache index values, pain pressure 
threshold, and active cervical ROM, and also found no difference between groups. 
However there was no control group of standard care or no care to give a true 
comparison. In a study of similar design, Yagci et al (2004) randomised 40 people 
with cervical myofascial pain syndrome to receive either CTM (15 sessions, 
intervention duration unclear) or a spray-stretch technique, with both groups also 
having an exercise intervention. Both groups showed a statistically significant 
improvement in pain (VAS), number of trigger points, and cervical range of motion 
after the treatment. In similar manner, Ekici et al (2009) carried out a trial in which 50 
women with fibromalgia were randomised to receive either CTM or manual lymph 
drainage 5 times per week for 3 weeks. This study was described as an RCT but it 
had no control group. Positive findings were reported for both groups in pain, health-
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related quality of life, and health status (Turkish Fibromalgia Impact Questionnaire). 
McKechnie et al (1983) described the effect of CTM in 5 patients with pain of varying 
sorts. There was no control group and no statistical analysis of group data, but some 
reductions in heart rate were observed. These studies show some evidence of 
beneficial effects from CTM but, without any control group, isolating the true CTM 
effect is problematic. In an experimental single case study, where collecting baseline 
data prior to the intervention being applied means that the patient acts as his/her 
own control, Holey and Lawler (1995) showed CTM to be better than classical 
abdominal massage at reducing constipation and improving consistency of stool. 
Although this methodology identified a trend for improvement through statistical 
comparison of the pre-intervention and intervention phases, there was no 
generalisation to other individuals, so the results should be treated with caution.  
 
Summary of clinical evidence 
In clinical research there are only a very small number of well-designed controlled 
trials with definitive evidence regarding CTM treatment effects. That small body of 
evidence does indicate a positive treatment effect, and seems to indicate CTM may 
be beneficial, perhaps as an adjunct to standard treatments. However most of the 
studies published in the area either have no control group or are studies of CTM in 
combination with other interventions, which markedly affects what can be 
generalised about actual CTM treatment. These uncontrolled studies can be viewed 
as phase I or II trials that seem to show evidence of effect, and which need following 
up with trials using a control group (Pocock, 1983). This scarcity of controlled studies 
of CTM is disappointing. If the aim of a study is to determine the effect of a 
treatment, it is essential to have a comparison control group (Altman, 1991). Without 
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a control group it is hard to determine if a new treatment has a real effect, and what 
the magnitude is (Friedman et al., 2010 ). This is because trials without a control arm 
such as a pre-post design can overestimate benefits due to factors such as temporal 
changes, regression to the mean, Hawthorne effects or any factors producing a bias 
(Torgerson &  Torgerson, 2008). Trials with a no-treatment control arm may be 
unethical, but trials comparing CTM against standard or usual care would not be 
problematic and would provide the answers needed about CTM. The studies of 
mixed interventions do not help answer the question posed, as generalisations about 
the true effect of CTM cannot be made from them. Nevertheless, these combined 
treatment studies do suggest potentially positive benefits.  
 
Overall, there is a small amount of evidence that CTM is beneficial. Further 
uncontrolled studies or investigations of combined interventions also a indicate 
potential for positive benefits, and suggest that at least pilot exploratory RCTs are 
warranted in those areas. Clearly, further well-designed RCTs are needed to 




CTM appears to work via a reflex effect on the autonomic nervous system which is 
induced by manipulating the fascial layers within and beneath the skin. There is 
some evidence that CTM produces physiological effects on the body. Regarding 
clinical effectiveness however, very few well designed controlled trials have been 
published using CTM, but these studies do indicate clinical benefit in relation to pain 
and peripheral circulation. This reflects the clinical experience of CTM users and the 
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physiological understanding of how CTM works. The majority of published clinical 
studies in to CTM unfortunately contain no control groups or are of combined 
treatments. Further research is needed to fully understand the mechanisms and 
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FIGURE 3 Layers of the skin and circulatory plexi Reproduced, with permission, from 
Holey and Cook p. 11 Reproduced from Holey (1995) Originally published in Schuh 
1994 Bindegewebsmassage Fishcer-Verlag, Stuttgart  
 
 
